Profound Reduction in T-helper (Th) 1 lymphocytes in Peripheral Blood from Patients with Concurrent Type 1 Diabetes and Graves' Disease

Type 1 diabetes likely is mediated by T-helper (Th) 1 lymphocytes, while Graves' disease may involve Th2 predominance. We investigated the balance between Th1 and Th2 cells and between Th1- and Th2-associated chemokine receptor expression on peripheral lymphocytes in subjects including patients...

Full description

Saved in:
Bibliographic Details
Published inENDOCRINE JOURNAL Vol. 53; no. 3; pp. 377 - 385
Main Authors YOSHIMASA ASO, HIROMI MATSUURA, ATSUSHI MOMOBAYASHI, YOSHIHISA INUKAI, NAOTO SUGAWARA, TOMOKI NAKANO, RURIKO YAMAMOTO, SADAO WAKABAYASHI, KOHZO TAKEBAYASHI, TOSHIHIKO INUKAI
Format Journal Article
LanguageJapanese
Published The Japan Endocrine Society 2006
Online AccessGet full text

Cover

Loading…
More Information
Summary:Type 1 diabetes likely is mediated by T-helper (Th) 1 lymphocytes, while Graves' disease may involve Th2 predominance. We investigated the balance between Th1 and Th2 cells and between Th1- and Th2-associated chemokine receptor expression on peripheral lymphocytes in subjects including patients with coexisting type I diabetes and Graves' disease. Peripheral blood mononuclear cells of all subjects were examined by flow cytometry for intracellular cytokines (IFN-γ for Th1;IL-4 for Th2) and expression of the chemokine receptors CXCR3 (Th1-associated) and CCR4 (Th2-associated). Plasma concentrations of interferon-inducible protein (IP)-10, a CXCR3 ligand, and thymus and activation-regulated chemokine (TARC), a CCR4 ligand, were measured by enzyme-linked immunosorbent assays. IFN-γ producing-T lymphocytes were significantly fewer in patients with coexisting type 1 diabetes and Graves' disease (12.4 ± 6.8%, n=6) than in healthy control subjects (19.9 ± 4.1%, n=6;P<0.01) or patients with type 2 diabetes (19.1 ± 4.5%, n=5;P<0.05). We found no significant difference in IFN-γ-producing T lymphocytes between healthy controls and patients with only type 1 diabetes (n=8) or Graves' disease (n=5). Plasma IP-10 concentrations were significantly higher in patients with coexisting type 1 diabetes and Graves' disease than in control subjects (106.3 ± 30.48 vs. 66.7 ± 25.3 pg/ml. P=0.0343). Considering only patients with type 1 diabetes alone, duration of diabetes correlated positively with IFN-γ-producing T lymphocytes (r=0.773, P=0.0242) and the ratio of CXCR3 to CCR4 receptor expression (r=0.947, P=0.0004). In conclusion, Th1-associated T lymphocytes were fewer in peripheral blood from patients having both type 1 diabetes and Graves' disease than in those with either disease alone. Numbers of peripheral Th1 lymphocytes increased with increasing time from onset of type 1 diabetes in patients with type 1 diabetes alone.
ISSN:0918-8959